Age Shift in Patterns of Injection Drug Use Among the HIV_AIDS Population in Miami-Dade County, Florida

Lieb, Spencer; Rosenberg, Rhonda; Arons, Paul; Malow, Robert M.; Liberti, Thomas M.; Maddox, Lorene M.; Friedlander, Linda; LaLota, Marlene; Farrell, Nisha; Grigg, Becky

doi:10.1080/10826080600847985

Cited by 7 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is an important (even if not terribly surprising) discovery, because it highlights the importance of avoiding a “one size fits all” approach to HIV intervention among MSM. Other authors have spoken about the need to provide age-specific educational efforts and interventions targeting HIV risk practices [20,60,61], including the need to implement such programs among MSM [62], and the present study’s findings strongly support this recommendation as well.…”

Section: Discussionsupporting

confidence: 78%

A comparison of HIV risk practices among unprotected sex-seeking older and younger men who have sex with other men

Klein¹

2012

The Aging Male

View full text Add to dashboard Cite

Purpose: In recent years, much attention has been devoted to understanding the HIV risk behaviors of younger men who have sex with men (MSM). Recent data suggest that HIV is becoming an increasing problem for older adults, but little attention has been devoted to understanding their HIV risk behaviors or the factors that underlie their risk taking. This study provides a comparison of these issues among younger and older MSM. Methods: The data come from a subset of younger (ages 18–39, n = 113) and older (ages 50+, n = 109) men participating in a national study of 332 men who use the Internet to find other men for unprotected sex. Men were sampled randomly from 16 websites. Data were collected via telephone interviews conducted in 2008 and 2009. Results: Younger and older men reported comparable involvement in HIV risk, including involvement in unprotected sex, proportion of sex acts involving internal ejaculation, number of times having anonymous sex, and number of times having multiple-partner sex. Generally speaking, the factors underlying the risk practices of younger and older men were quite different (e.g. self-esteem and condom use self-efficacy for younger men, versus HIV serostatus and depression for older men). Conclusions: Older MSM using the Internet to find partners for unprotected sex engage in high rates of behaviors that place them at risk for contracting or transmitting HIV. They were just as likely as their younger counterparts to practice these behaviors. The factors “fueling” involvement in risk generally differ for older and younger men, thereby warranting the development of age-specific HIV interventions that can take into account the unique life circumstances and needs of older MSM.

show abstract

Section: Discussionsupporting

confidence: 78%

A comparison of HIV risk practices among unprotected sex-seeking older and younger men who have sex with other men

Klein¹

2012

The Aging Male

View full text Add to dashboard Cite

show abstract

“…As young people are prone to risk-taking behaviors, and cities in developing countries have a high proportion of young people, it was expected that youth would comprise much of our sample. Furthermore, many studies also support that young people are prone to substance use [ 43 – 45 ]. Similarly, research from other contexts also reports a higher proportion of men compared to women who use injection drugs [ 46 – 48 ].…”

Section: Discussionmentioning

confidence: 99%

Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia

et al. 2020

View full text Add to dashboard Cite

Background Injecting drug use is known to contribute significantly to the spread of the HIV epidemic in many parts of the developing world. Due to the hidden nature and stigma of the problem, it is difficult to study using routine surveys. Therefore, this study aims to estimate the number of people who inject drugs in Addis Ababa, Ethiopia, and to describe the epidemiological and social situation related to HIV among people who inject drugs. Methods The study used rapid assessment methods, followed by combined methods of estimating populations, using nomination and multiplier methods. The combined methods used two datasets: the first includes the proportion of people who use services within a year as a multiplier, and the second, a count of the list of people with a problem who used the specific service within a year as a benchmark. The rapid assessment incorporated different qualitative tools to elicit information related to injectable drugs, using existing data sources, in-depth interviews, and focus group discussions. Results The study estimated a total of 4068; with 95% CI (3196, 5207) people who inject drugs (PWIDs) in Addis Ababa. The study found people who inject drugs were young in age, male, with a lower educational status, unmarried, and living in small clerical business. People who inject drugs and participated in the study were more likely to use additional substances like alcohol, khat, and cannabis. The most common form of injectable drug used was heroin, and most of the people who inject drugs reported sharing syringes and needles. A high proportion of study subjects also disclosed having positive test results for HIV, hepatitis B, and C. Conclusion The population size of people who inject drugs in Addis Ababa is high. Lack of service in harm reduction in the city has made PWIDs vulnerable and at higher risk for HIV/AIDs and hepatitis B and C. Therefore, responsible bodies must start implementing the essential harm reduction strategies given by the World Health Organization.

show abstract

“…South Florida suffers from multiple epidemics. In addition to the current COVID-19 crisis, South Florida has one of the highest HIV incidence rates in the nation [ 17 ], an epidemic that has been strongly linked to drug use in Miami, Florida [ 18 – 20 ]. The clinical impact of HIV infection on the natural history of COVID-19 is uncertain, although limited evidence suggests that PLWH are not at greater risk of infection, severe disease, or death than the general population, if they are effectively treated with antiretroviral therapy (ART) [ 21 , 22 ].…”

Section: Introductionmentioning

confidence: 99%

Resilience, Anxiety, Stress, and Substance Use Patterns During COVID-19 Pandemic in the Miami Adult Studies on HIV (MASH) Cohort

et al. 2021

View full text Add to dashboard Cite

We evaluated mental health and substance use during the COVID-19 pandemic in 196 participants from the Miami Adult Studies on HIV (MASH) Cohort. A survey was administered between July-August of 2020, including validated measures of resilience and anxiety, a scale to measure COVID-19-related worry, and self-reported substance use. Compared to HIVuninfected participants (n = 80), those living with HIV (n = 116) reported fewer anxiety symptoms, less COVID-19-related worry, and higher resilience. Those with more anxiety symptoms and lower resilience engaged in more frequent alcohol consumption, binge drinking, and cocaine use. Alcohol misuse was more common among HIV-uninfected participants. Cocaine use was reported by 21% fewer participants during the pandemic compared with 7.3 ± 1.5 months earlier. Possibly due to their experiences with HIV, PLWH responded with higher resilience and reduced worry and anxiety to the adversities brought by the COVID-19 pandemic.

show abstract

Age Shift in Patterns of Injection Drug Use Among the HIV_AIDS Population in Miami-Dade County, Florida

Cited by 7 publications

References 15 publications

A comparison of HIV risk practices among unprotected sex-seeking older and younger men who have sex with other men

A comparison of HIV risk practices among unprotected sex-seeking older and younger men who have sex with other men

Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia

Resilience, Anxiety, Stress, and Substance Use Patterns During COVID-19 Pandemic in the Miami Adult Studies on HIV (MASH) Cohort

Contact Info

Product

Resources

About